Ceruloplasmin metabolism and function

Annual Review of Nutrition

Volumn 22, Issue , 2002, Pages 439-458

  Hellman, Nathan E ^a   Gitlin, Jonathan D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aceruloplasminemia; Copper; Iron; Neurodegeneration; Wilson disease

Indexed keywords

CERULOPLASMIN;

ACERULOPLASMINEMIA; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION; GENE MUTATION; GENE STRUCTURE; HUMAN; IRON KINETICS; IRON TRANSPORT; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN METABOLISM; REVIEW; WILSON DISEASE;

CERULOPLASMIN; COPPER; HUMANS; IRON; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION;

EID: 0036400025     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.22.012502.114457     Document Type: Review

References (107)

1. Abboud S, Haile DJ. 2000. A novel mammalian iron-regulated protein involved in intracellular iron metabolism and nutrition. J. Biol. Chem. 275:19906-12
2. Aldred AR, Grimes A, Schreiber G, Mercer JF. 1987. Rat ceruloplasmin. Molecular cloning and gene expression in liver, choroid plexus, yolk sac, placenta, and testis. J. Biol. Chem. 262:2875-78
3. Andrews NC. 1999. Disorders of iron metabolism. N. Engl. J. Med. 341:1986-95
4. Andrews NC. 2000. Iron homeostasis: Insights from genetics and animal models. Nat. Rev. Genet. 1:208-17
5. Arrese M, Ananthananarayanan M, Suchy FJ. 1998. Hepatobiliary transport: Molecular mechanisms of development and cholestasis. Pediatr. Res. 44:141-47
6. Askwith C, Eide D, VanHo A, Bernard PS, Li L, et al. 1994. The FET3 gene of S. cerevisiae encodes a multicopper oxidase required for ferrous iron uptake. Cell 76: 403-10
7. Calabrese L, Carbonaro M, Musci G. 1989. Presence of coupled trinuclear copper cluster in mammalian ceruloplasmin is essential for efficient electron transfer to oxygen. J. Biol. Chem. 264:6183-87
8. Cartwright GE, Markowitz H, Shields S, Wintrobe MM. 1960. Studies on copper metabolism. XXIX. Am. J. Med. 28:555-63
9. Church WR, Jernigan RL, Toole J, Hewick RM, Knopf J, et al. 1984. Coagulation factors V and VIII and ceruloplasmin constitute a family of structurally related proteins. Proc. Nat. Acad. Sci. USA 81:6934-37
10. Cox DW. 1966. Factors influencing serum ceruloplasmin levels in normal individuals. J. Lab. Clin. Med. 68:893-904
11. Craven CM, Alexander J, Eldridge M, Kushner JP, Bernstein S, et al. 1987. Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: A rodent model for hemochromatosis. Proc. Natl. Acad. Sci. USA 84:3457-61
12. Curtis AR, Fey C, Morris CM, Bindoff LA, Ince PG, et al. 2001. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat. Genet. 28:350-54
13. Daimon M, Kato T, Kawanami T, Tominaga M, Igarashi M, et al. 1995. A nonsense mutation of the ceruloplasmin gene in hereditary ceruloplasmin deficiency with diabetes mellitus. Biochem. Biophys. Res. Commun. 217:89-95
14. Daimon M, Moriai S, Susa S, Yamatani K, Hosoya T, et al. 1999. Hypocaeruloplasminaemia with heteroallelic caeruloplasmin gene mutation: MRI of the brain. Neuroradiology 41:185-57
15. Daimon M, Susa S, Ohizumi T, Moriai S, Kawanami T, et al. 2000. A novel mutation of the ceruloplasmin gene in a patient with heteroallelic ceruloplasmin gene mutation (HypoCPGM). Tohoku J. Exp. Med. 191:119-25
16. Daimon M, Yamatani K, Igarashi M, Fukase N, Kawanami T, et al. 1995. Fine structure of the human ceruloplasmin gene. Biochem. Biophys. Res. Commun, 208:1028-35
17. Davis-Kaplan SR, Askwith CC, Bengtzen AC, Radisky D, Kaplan J. 1998. Chloride is an allosteric effector of copper assembly for the yeast multicopper oxidase fet3p: An unexpected role for intracellular chloride channels. Proc. Natl. Acad. Sci. USA 95:13641-45
18. Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, et al. 2000. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403:776-81
19. Edwards CQ, Williams DM, Cartwright GE. 1979. Hereditary hypoceruloplasminemia. Clin. Genet. 15:311-16
20. Eide D, Bridgham JT, Zhao Z, Matoon JR. 1993. The vacuolar H+ ATPase of Saccharomyces cerevisiae is required for efficient copper detoxification, mitochondrial function and iron metabolism. Mol. Gen. Genet. 241:447-56
21. Endo M, Suzuki K, Schmid K, Fournet B, Karamanos Y, et al. 1982. The structures and microheterogeneity of the carbohydrate chains of human plasma ceruloplasmin. A study employing 500-MHz 1HNMR spectroscopy. J. Biol. Chem. 257: 8755-60
22. Fleming R, Gitlin JD. 1990. Primary structure of rat ceruloplasmin and analysis of tissue-specific gene expression during development. J. Biol. Chem. 265:7701-7
23. Fortna RR, Watson HA, Nyquist SE. 1999. Glycosyl phosphatidylinositol-anchored ceruloplasmin is expressed by rat Sertoli cells and is concentrated in detergentinsoluble membrane fractions. Biol. Reprod. 61:1042-49
24. Gaxiola RA, Yuan DS, Klausner RD, Fink GR. 1998. The yeast CLC chloride channel functions in cation homeostasis. Proc. Natl. Acad. Sci. USA 95:4046-50
25. Gitlin JD. 1988. Transcriptional regulation of ceruloplasmin gene expression during inflammation. J. Biol. Chem. 263: 6281-87
26. Gitlin JD. 1998. Aceruloplasminemia. Pediatr. Res. 44:271-76
27. Gitlin D, Biasucci A. 1969. Development of gamma G, gamma A, gamma M, beta IC-beta IA, C 1 esterase inhibitor, ceruloplasmin, transferrin, hemopexin, haptoglobin, fibrinogen, plasminogen, alpha 1-antitrypsin, orosomucoid, beta-lipoprotein, alpha 2-macroglobulin, and prealbumin in the human conceptus. J. Clin. Invest. 48:1433-46
28. Gitlin D, Janeway CA. 1960. Turnover of the copper and protein moieties of ceruloplasmin. Nature 185:693
29. Gitlin D, Janeway CA. 1960. Absorption and excretion of copper in mice. Nature 188:150-51
30. Gitlin JD, Schroeder JJ, Lee-Ambrose LM, Cousins RJ. 1992. Mechanisms of caeruloplasmin biosynthesis in normal and copper-deficient rats. Biochem. J. 282:835-39
31. Hamza I, Faisst A, Prohaska J, Chen J, Gruss P, et al. 2001. The metallochaperone atox1 plays a critical role in perinatal copper homeostasis. Proc. Natl. Acad. Sci. USA 98:6848-52
32. Hamza I, Schaefer M, Klomp LWJ, Gitlin JD. 1999. Interaction of the copper chaperone HAH1 with the Wilson disease protein is essential for copper homeostasis. Proc. Natl. Acad. Sci. USA 96:13363-68
33. Harris ZL, Durley AP, Man TK, Gitlin JD. 1999. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc. Natl. Acad. Sci. USA 96:10812-17
34. Harris ZL, Klomp LW, Gitlin JD. 1998. Aceruloplasminemia: An inherited neurodegenerative disease with impaired iron homeostasis. Am. J. Clin. Nutr. 67:972S-77S
35. Harris ZL, Migas MD, Hughes AE, Logan JL, Gitlin JD. 1996. Familial dementia due to a frameshift mutation in the caeruloplasmin gene. Q. J. Med. 89:355-59
36. Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RT. 1995. Aceruloplasminemia: Molecular characterization of this disorder of iron metabolism. Proc. Natl. Acad. Sci. USA 92:2539-43
37. Hellman NE, Kono S, Miyajima H, Gitlin JD. 2002. Biochemical analysis of a missense mutation in aceruloplasminemia. J. Biol. Chem. 277:1375-80
38. Hellman NE, Schaefer M, Gehrke S, Stegen P, Hoffman WJ, et al. 2000. Hepatic iron overload in aceruloplasminaemia. Gut 47:858-60
39. Holmberg CG, Laurell CB. 1948. Investigations in serum copper. II. Isolation of the copper-containing protein and a description of some of its properties. Acta Chem. Scand. 2:550-56
40. Holtzman NA, Elliott DA, Heller RH. 1966. Copper intoxication. Report of a case with observations on ceruloplasmin. N. Engl. J. Med. 275:347-52
41. Holtzman NA, Gaumnitz BM. 1970. Identification of an apoceruloplasmin-like substance in the plasma of copper-deficient rats. J. Biol. Chem. 245:2350-53
42. Holtzman NA, Gaumnitz BM. 1970. Studies on the rate of release and turnover of ceruloplasmin and apoceruloplasmin in rat plasma. J. Biol. Chem. 245:2354-58
43. Hung IH, Suzuki M, Yamaguchi Y, Yuan DS, Klausner RD, Gitlin JD. 1997. Biochemical characterization of the Wilson disease protein and functional expression in the yeast Saccharomyces cerevisiae. J. Biol. Chem. 272:21461-66
44. Klomp LWJ, Farhangrazi ZS, Dugan LL, Gitlin JD. 1996. Ceruloplasmin gene expression in the murine central nervous system. J. Clin. Invest. 98:207-15
45. Klomp LWJ, Gitlin JD. 1996. Expression of the ceruloplasmin gene in the human retina and brain: Implications for a pathogenic model in aceruloplasminemia. Hum. Mol. Genet. 5:1989-96
46. Kohno S, Miyajima H, Takahashi Y, Inoue Y. 2000. Aceruloplasminemia with a novel mutation associated with parkinsonism. Neurogenetics 2:237-48
47. Koschinsky ML, Chow BK-C, Schwartz J, Hamerton JL, MacGillivray RTA. 1987. Isolation and characterization of a processed gene for human ceruloplasmin. Biochemistry 26:7760-67
48. Koschinsky ML, Funk WD, VanOost BA, MacGillivray RT. 1986. Complete cDNA sequence of human preceruloplasmin. Proc. Natl. Acad. Sci. USA 83:5086-90
49. Larin D, Mekios C, Das K, Ross B, Yang AS, et al. 1999. Characterization of the interaction between the Wilson and Menkes disease proteins and the cytoplasmic copper chaperone, HAH1p. J. Biol. Chem. 274:28497-504
50. Laurell CB, Kullander S, Thorell J. 1968. Effect of administration of a combined estrogen-progestin contraceptive on the level of individual plasma proteins. Scand. J. Clin. Lab. Invest. 21:337-43
51. Lee GR, Nacht S, Lukens JN, Cartwright GE. 1968. Iron metabolism in copper-deficient swine. J. Clin. Invest. 47:2058-69
52. Libby P. 2001. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104:365-72
53. Logan JL, Harveyson KB, Wisdom GB, Hughes AE, Archibold GP. 1994. Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus. Q. J. Med. 87:663-70.
54. Loudianos G, Gitlin JD. 2000. Wilson disease. Semin. Liver Dis. 20:353-64
55. Machonkin TE, Quintanar L, Palmer AE, Hassett R, Severance S, et al. 2001. Spectroscopy and reactivity of the type 1 copper site in Fet3p from Saccharomyces cerevisiae: Correlation of structure with reactivity in the multicopper oxidases. J. Am. Chem. Soc. 123:5507-17
56. Mackiewicz A, Ganapathi MK, Schultz D, Kushner I. 1987. Monokines regulate glycosylation of acute-phase proteins. J. Exp. Med. 166:253-58
57. Matsuda I, Pearson T, Holtzman NA. 1974. Determination of apoceruloplasmin by radioimmunoassay in nutritional copper deficiency, Menkes' kinky hair syndrome, Wilson's disease, and umbilical cord blood. Pediatr. Res. 8:821-24
58. McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, et al. 2000. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol. Cell 5:299-309
59. Messerschmidt A, Huber R. 1990. The blue oxidases, ascorbate oxidase, laccase and ceruloplasmin. Modeling and structural relationships. Eur. J. Biochem. 187: 341-52
60. Messerschmidt A, Rossi A, Ladenstein R, Huber R, Bolognesi M, et al. 1989. X-ray crystal structure of the blue oxidase ascorbate oxidase from zucchini. Analysis of the polypeptide fold and a model of the copper sites and ligands. J. Mol. Biol. 206:513-29
61. Meyer LA, Durley AP, Prohaska JR, Harris ZL. 2001. Copper transport and metabolism are normal in aceruloplasminemic mice. J. Biol. Chem. 276:36857-61
62. Miyajima H, Adachi J, Kohno S, Takahashi Y, Ueno Y. 2001. Increased oxysterols associated with iron accumulation in the brains and visceral organs of acaeruloplasminaemia patients. Q. J. Med. 94: 417-22
63. Miyajima H, Adachi J, Tatsuno Y, Takahashi Y, Fujimoto M, et al. 1998. Increased very long-chain fatty acids in erythrocyte membranes of patients with aceruloplasminemia. Neurology 50:130-36
64. Miyajima H, Fujimoto M, Kohno S, Kaneko E, Gitlin JD. 1998. CSF abnormalities in patients with aceruloplasminemia. Neurology 51:1188-90
65. Miyajima H, Kono S, Takahashi Y, Sugimoto M, Sakamoto M, et al. 2001. Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation. Neurology 57:2205-10
66. Miyajima H, Kohno S, Takahashi Y, Yonekawa O, Kanno T. 1999. Estimation of the gene frequency of aceruloplasminemia in Japan. Neurology 53:617-29
67. Miyajima H, Nishimura Y, Mizoguchi K, Sakanoto M, Shimizu T, et al. 1987. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 37:761-67
68. Miyajima H, Takahashi Y, Kamata T, Shimizu H, Sakai N, et al. 1997. Use of desferrioxamine in the treatment of aceruloplasminemia. Ann. Neurol. 41:404-47
69. Miyajima H, Takahashi Y, Serizawa M, Kaneko E, Gitlin JD. 1996. Increased plasma lipid peroxidation in patients with aceruloplasminemia. Free Radic. Biol. Med. 20:757-60
70. Mohrenweiser HW, Decker RS. 1982. Identification of several electrophoretic variants of human ceruloplasmin including CpMichigan, a new polymorphism. Hum. Hered. 32:369-73
71. Mollgard K, Dziegielewska KM, Saunders NR, Zakut H, Soreq H. 1998. Synthesis and localization of plasma proteins in the developing human brain. Integrity of the fetal blood-brain barrier to endogenous proteins of hepatic origin. Dev. Biol. 128:207-21
72. Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, et al. 2001. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLCllA3) gene. J. Clin. Invest. 108: 619-23
73. Morita H, Ikeda S, Yamamoto K, Morita S, Yoshida K, et al. 1995. Hereditary ceruloplasmin deficiency with hemosiderosis: A clinicopathological study of a Japanese family. Ann. Neurol. 37:646-56
74. Murata Y, Yamakawa E, Iizuka T, Kodama H, Abe T, et al. 1995. Failure of copper incorporation into ceruloplasmin in the Golgi apparatus of LEC rat hepatocytes. Biochem. Biophys. Res. Commun. 209:349-55
75. Njajou OT, Vaessen N, Joosse M, Berghuis B, van Dongen JWA, et al. 2001. Mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat. Genet. 28:213-14
76. Okamoto N, Wada S, Oga T, Kawabata Y, Baba Y, et al. 1996. Hereditary ceruloplasmin deficiency with hemosiderosis. Hum. Genet. 97:755-58
77. Olivares M, Uauy R. 1996. Copper as an essential nutrient. Am. J. Clin. Nutr. 63: 791S-96S
78. Osaki S, Johnson D, Frieden E. 1966. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J. Biol. Chem. 241:2746-57
79. Osaki S, Johnson DA, Frieden E. 1971. The mobilization of iron from the perfused mammalian liver by a serum copper enzyme, ferroxidase. J. Biol. Chem. 246: 3018-23
80. Patel BN, David S. 1997. A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J. Biol. Chem. 272:20185-90
81. Patel BN, Dunn RJ, David S. 2000. Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain. J. Biol. Chem. 275:4305-10
82. Pollitt E. 1993. Iron deficiency and cognitive function. Annu. Rev. Nutr. 13:521-37
83. Rae TD, Schmidt PJ, Pufahl RA, Culotta VC, O'Halloran TV. 1999. Undetectable intracellular free copper: The requirement of a copper chaperone for superoxide dismutase. Science 284:805-8
84. Roeser HP, Lee GR, Nacht S, Cartwright GE. 1970. The role of ceruloplasmin in iron metabolism. J. Clin. Invest. 49:2408-17
85. Rosenzweig AC. 2000. Copper delivery by metallochaperone proteins. Acc. Chem. Res. 34:119-28
86. Salzer JL, Lovejoy L, Linder MC, Rosen C. 1998. Ran-2, a glial lineage marker, is a GPI-anchored form of ceruloplasmin. J. Neurosci. Res. 54:147-57
87. Sato M, Gitlin JD. 1991. Mechanisms of copper incorporation during the biosynthesis of human ceruloplasmin. J. Biol. Chem. 266:5128-34
88. Schaefer M, Gitlin JD. 1999. Genetic disorders of copper transport. Am. J. Physiol. 276:G311-14
89. Schaefer M, Hopkins RG, Failla ML, Gitlin JD. 1999. Hepatocyte-specific localization, copper-dependent trafficking and developmental expression of the Wilson disease protein in the liver. Am. J. Physiol. Gastrointest. Liver Physiol. 276:G639-G46
90. Scheinberg IH, Gitlin D. 1952. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). Science 116:484-89
91. Spizzo T, Byersdorfer C, Duesterhoeft S, Eide D. 1997. The yeast FET5 gene encodes a FET3-related multicopper oxidase implicated in iron transport. Mol. Gen. Genet. 256:547-56
92. Stearman R, Yuan DS, Yamaguchi-Iwa Y, Klausner RD, Dancis A. 1996. A permease-oxidase complex involved in high-affinity iron uptake in yeast. Science 271:1552-57
93. 67. J. Clin. Invest. 40:1834-40
94. Takahashi N, Ortel TL, Putnam FW. 1984. Single-chain structure of human ceruloplasmin: The complete amino acid sequence of the whole molecule. Proc. Natl. Acad. Sci. USA 81:390-94
95. Takahashi Y, Miyajima H, Shirabe S, Nagataki S, Suenaga A, et al. 1995. Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease. Hum. Mol. Genet. 51:81-84
96. Terada K, Kawarada Y, Miura N, Yasui O, Koyama K, et al. 1995. Copper incorporation into ceruloplasmin in rat livers. Biochim. Biophys. Acta. 1270:58-62
97. Thompson KJ, Shoham S, Connor JR. 2001. Iron and neurodegenerative disorders. Brain Res. Bull. 55:155-64
98. Urbanowski JL, Piper RC. 1999. The iron transporter Fthlp forms a complex with the Fet5 iron oxidase and resides on the vacuolar membrane. J. Biol. Chem. 274:38061-70
99. Vulpe CD, Kuo YM, Murphy TL, Cowley L, Askwith C, et al. 1999. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat. Genet. 21:195-99
100. Yang F, Friedrichs WE, deGraffenried L, Herbert DC, Weaker FJ, et al. 1996. Cellular expression of ceruloplasmin in baboon and mouse lung during development and inflammation. Am. J. Respir. Cell. Mol. Biol. 14:161-69
101. Yang F, Naylor SL, Lum JB, Cutshaw S, McCombs JL, et al. 1986. Characterization, mapping and expression of the human ceruloplasmin gene. Proc. Natl. Acad. Sci. USA 83:3257-61
102. Yang FM, Friedrichs WE, Cupples RL, Bonifacio MJ, Sanford JA, et al. 1990. Human ceruloplasmin. Tissue-specific expression of transcripts produced by alternative splicing. J. Biol. Chem. 26510780-85
103. Yazaki M, Yoshida K, Nakamura A, Furihata K, Yonekawa M, et al. 1998. A novel splicing mutation in the ceruloplasmin gene responsible for hereditary ceruloplasmin deficiency with hemosiderosis. J. Neurol. Sci. 156:30-34
104. Yonekawa M, Okabe T, Asamoto Y, Ohta M. 1999. A case of hereditary ceruloplasmin deficiency with iron deposition in the brain associated with chorea, dementia, diabetes mellitus and retinal pigmentation: Administration of fresh-frozen human plasma. Eur. Neurol. 42:157-62
105. Yoshida K, Furihata K, Takeda S, Nakamura A, Yamamoto K, et al. 1995. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat. Genet. 9:267-72
106. Yoshida K, Kaneko K, Miyajima H, Tokuda T, Nakamura A, et al. 2000. Increased lipid peroxidation in the brains of aceruloplasminemia patients. J. Neurol. Sci. 175:91-95
107. Zaitseva I, Zaitsev V, Card G, Moshkov K, Bax B, et al. 1996. The x-ray structure of human serum ceruloplasmin at 3.1 Å: Nature of the copper centres. J. Biol. Inorg. Chem. 1:15-23